Tobramycin Inhalation Solution (Bethkis) for Cystic Fibrosis

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2014年 / 56卷 / 1445期
关键词：
PSEUDOMONAS-AERUGINOSA;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：51 / 52
页数：2
相关论文
共 50 条
  • [1] Tobramycin solution for inhalation in cystic fibrosis patients: a review of the literature
    Hagerman, Jennifer K.
    Knechtel, Stephanie A.
    Klepser, Michael E.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (04) : 467 - 475
  • [2] Mortality of cystic fibrosis patients treated with tobramycin solution for inhalation
    Rothman, KJ
    Wentworth, CE
    [J]. EPIDEMIOLOGY, 2003, 14 (01) : 55 - 59
  • [3] TOBRAMYCIN INHALATION POWDER VS TOBRAMYCIN INHALATION SOLUTION FOR CYSTIC FIBROSIS: RESPONSE BY AGE GROUP IN THE EAGER TRIAL
    Geller, D. E.
    Nasr, S.
    Piggott, S.
    Angyalosi, G.
    Higgins, M.
    [J]. PEDIATRIC PULMONOLOGY, 2011, : 337 - 338
  • [4] Tobramycin Inhalation Powder Is As Effective As Tobramycin Inhalation Solution In Patients With Cystic Fibrosis: A Subgroup Analysis Of The Eager Trial
    Konstan, M. W.
    Parkins, M.
    Angyalosi, G.
    Higgins, M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [5] EFFECT OF TOBRAMYCIN INHALATION SOLUTION ON MORTALITY IN SUBGROUPS OF PATIENTS WITH CYSTIC FIBROSIS
    Latremouille-Viau, D.
    Sawicki, G. S.
    Zhang, J.
    von Wartburg, M.
    Signorovitch, J.
    Wu, E. Q.
    Shi, L.
    [J]. PEDIATRIC PULMONOLOGY, 2011, : 346 - 346
  • [6] Population Pharmacokinetics of Tobramycin Inhalation Solution in Pediatric Patients With Cystic Fibrosis
    Wang, Xinting
    Koehne-Voss, Stephan
    Anumolu, SivaNaga S.
    Yu, Jing
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 106 (11) : 3402 - 3409
  • [7] Reduced mortality in cystic fibrosis patients treated with tobramycin inhalation solution
    Sawicki, Gregory S.
    Signorovitch, James E.
    Zhang, Jie
    Latremouille-Viau, Dominick
    von Wartburg, Markus
    Wu, Eric Q.
    Shi, Lizheng
    [J]. PEDIATRIC PULMONOLOGY, 2012, 47 (01) : 44 - 52
  • [8] Inhalation of tobramycin in cystic fibrosis - Part 2. Optimization of the tobramycin solution for a jet and an ultrasonic nebulizer
    Le Brun, PPH
    de Boer, AH
    Gjaltema, D
    Hagedoorn, P
    Heijerman, HGM
    Frijlink, HW
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 189 (02) : 215 - 225
  • [9] COMPARISON OF DRUG COSTS & CLINICAL OUTCOMES WITH TOBRAMYCIN SOLUTION FOR INHALATION & AZTREONAM LYSINE FOR INHALATION IN CYSTIC FIBROSIS
    Signorovitch, J.
    Latremouille-Viau, D.
    Dea, K.
    Wu, E.
    Zhang, J.
    [J]. PEDIATRIC PULMONOLOGY, 2010, : 309 - 309
  • [10] Tobramycin Inhalation Powder (Tobi Podhaler) for Cystic Fibrosis
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2013, 55 (1419): : 51 - 52
12345